From Research to Practice: The Latest Data on Evolving Treatments for Chronic Spontaneous Urticaria

September 2024 | Volume 23 | Issue 9 | 795 | Copyright © September 2024


Published online August 31, 2024

Melinda J. Gooderham MD MSc FRCPCa, Shawn G Kwatra MDb, Bob Geng MDc

aDepartment of Medicine, Queen's University; Peterborough Regional Health Centre; SKiN Centre for Dermatology, Peterborough, Ontario, Canada
bUniversity of Maryland School of Medicine, Baltimore, MD
cDivision of Allergy & Immunology; Rady Children's Hospital; Divisions of Adult and Pediatric Allergy and Immunology, San Diego, CA

Abstract
Chronic spontaneous urticaria (CSU) should be on every dermatology practitioner's radar. CSU is a skin disorder marked by wheals, angioedema, or both for more than 6 weeks. Patients with CSU experience unexplained, itchy wheals that appear and disappear, traveling around the body and lasting less than 24 hours per area. Angioedema accompanies wheals for up to 48 hours in around half of cases. CSU is a diagnosis of exclusion, relying heavily on patient history to differentiate CSU symptoms from other causes of urticaria or angioedema. But reassuringly, CSU has a simple diagnostic algorithm and a clear initial treatment path. First-line strategies include non-pharmacologic approaches, and second-generation antihistamines (2gAH) administered up to 4 times their standard dose. Omalizumab and cyclosporine (off-label) are second- and third-line options, respectively. However, many patients will continue to have CSU symptoms despite consistent maximum-dose treatment. Novel therapies, including biologic agents and small molecule drugs targeting mast cell activation and inflammatory mediators, show promise in treating CSU refractory to standard therapy. However, further research is needed to establish their efficacy and safety in clinical practice.

J Drugs Dermatol. 2024;23:9(Suppl 2):s5-14.

Access the CME Activity
Chronic spontaneous urticaria (CSU) is defined as the spontaneous appearance of wheals, angioedema, or both for more than 6 weeks.1,2 Unlike chronic inducible urticaria, CSU symptoms cannot be induced through provocation tests and are independent of environmental conditions and allergens. Visually, symptoms cannot be distinguished from other causes of urticaria or angioedema, making a detailed patient history crucial for diagnosis.

Signs and Symptoms
Patients with CSU will experience unexplained, pruritic hives called wheals. These wheals typically appear for less than 24 hours in one area before fading and reappearing in a different area of the body. Episodes of wheals appearing sporadically and seemingly at random can persist for several days.1 The associated pruritus can be severe and even disabling, leading some to refer to the condition as "the devil's itch."3 Though wheals present more frequently, 43% to 59% of patients will also experience angioedema.4 This swelling can last up to 48 hours. Roughly 10% of patients with CSU present with angioedema as their primary symptom.3

Pathophysiology
CSU is primarily mediated by dermal mast cells.5 These mast cells degranulate, triggering histamine-facilitated vasodilation and increased vascular permeability that manifests clinically as pruritic wheals or angioedema.5 The exact mechanism triggering this initial mast cell degranulation remains unclear.5 Three subtypes of CSU exist: type I (autoallergic, immunoglobulin [Ig]E mediated), type IIb (autoimmune, IgG autoantibody-mediated), and cause unknown.4,6 Type IIb is believed to cause higher disease activity than type I, but the utility of these subtypes in predicting treatment response or symptom burden is unclear (Figure 1).4

Burden of CSU Disease in the United States
An estimated 500,000 people suffer from chronic urticaria of any etiology, but the true figure is likely higher.7 When CSU